IMM 7.41% 29.0¢ immutep limited

min requirement for nasdaq listing, page-10

  1. 115 Posts.
    In response to Peace I agree that NASDAQ listing is not the be all and end all of PRR - they have agreat management team with excellent technology. But I know that I am keen for NASDAQ listing because until now and not even yet, PRR has not had a look in with institutions or analysts generally - unlike almost any junior mining stock - most of these have hade huge gains over the last 2 years, and yet PRRs potential is not 'in the ground'. They have already proven the technology of CVAC in phase 1 & 2 trials.

    It will be very satisfying for all of the believers in PRR to see others want to invest in this stock, based on its potential - I just think that overall Australian investors don't care much for australian biotechs and that is reflected in market sentiment and share price.

    These are just my opinions

    Good luck to all

    Spare Paper
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
0.020(7.41%)
Mkt cap ! $421.8M
Open High Low Value Volume
27.5¢ 29.5¢ 27.0¢ $1.138M 3.985M

Buyers (Bids)

No. Vol. Price($)
2 63444 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 65000 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.